Dr. Dinesh Kumar Jothimani

National & International Awards

• FRCP: Fellowship of the Royal College of Physicians and Surgeons, Glasgow (2018)
• CCT: Certificate of Completion of Training in Hepatology and Gastroenterology, UK (2010)
• Extensive citations (1,800+) for published research in high-impact journals.

Recognitions & Honors

• Recognised as a top Hepatologist in India for his work in liver regeneration and autoimmune hepatitis.
• Invited speaker at international forums including ILTS (International Liver Transplantation Society) and APASL (Asian Pacific Association for the Study of the Liver).

Dr. Dinesh Jothimani has over 145 publications and 18,000+ reads on research platforms. Below are selected key publications:

Published Papers in Medical Journals

• COVID-19 and Liver, Journal of Hepatology (2020)
• INASL Consensus Statement on Acute Liver Failure (Part-2): Management of Acute Liver Failure, Journal of Clinical and Experimental Hepatology (2020)
• Expanding transplant criteria for HCC beyond Milan is associated with high risk of early systemic tumor recurrence, Conference Paper (2019)
• Management of post liver transplantation recurrent hepatitis C infection with directly acting antiviral drugs: a review, Hepatology International (2016)
• Predicting Fatty Liver Disease in Healthy Potential Liver Donors, Conference Paper (2016)
• Macrophage secretory products induce an inflammatory phenotype in hepatocytes, World Journal of Gastroenterology (2012)
• Non-invasive assessment of fibrosis in liver grafts due to hepatitis C virus recurrence, Clinical Transplantation (2011)

Books & Chapters Authored

• Chapter: Liver in Systemic Disease, Elsevier Textbook (2022)
• Chapter: Hepatitis Non-A–E Viruses, INEDSYS Hepatology: A Comprehensive Textbook (2022)
• Chapter: Genetics of NASH, Role of Genetics in the Epidemiology and Pathogenesis of NAFLD (2020)
• Chapter: Liver Regeneration and Pathophysiology of Post-hepatectomy Liver Failure, Elsevier Liver Transplantation (2015)

Ongoing Clinical Trials Participation

• NASH and Liver Transplantation studies.
• Cardiovascular Disease effects in NASH Transplant Patients.
• Research into efficacy of Terlipressin in Variceal Bleeds.

Notable Cases Handled

• Successfully managed a complex case of acute liver failure in a young patient due to drug-induced toxicity, avoiding transplantation through intensive medical management.
• Coordinated the pre-and post-operative care for a high-risk hepatocellular carcinoma patient requiring a living donor liver transplant, resulting in disease-free survival.
• Treated numerous international patients for advanced cirrhosis and Hepatitis C utilizing the latest Direct-Acting Antiviral (DAA) protocols.

Patient Testimonials & Feedback

• Life-Saving Management of Acute Liver Failure

Patients presenting with acute liver failure often face a critical window where survival is uncertain. Dr. Jothimani has successfully managed numerous high-stakes cases of drug-induced and toxin-mediated liver failure in the ICU setting. Families frequently express deep gratitude for his "decisive and calm" medical intervention, which in several instances reversed the organ failure, saving the patient from the immediate need for an emergency transplant.

• Seamless Liver Transplant Journey

For patients suffering from decompensated cirrhosis, the path to transplantation is fraught with complications like severe ascites and infection. Dr. Jothimani is renowned for his ability to "bridge" these high-risk patients to surgery, optimising their health so they can withstand the procedure. Post-transplant recipients often cite his meticulous management of immunosuppression and complications as the key factor in their smooth recovery and return to a normal quality of life.

• Victory Over Chronic Hepatitis and HCC

Managing chronic viral hepatitis is crucial to preventing liver cancer. Dr. Jothimani has guided countless patients with Hepatitis B and C to complete viral suppression or cure using advanced Direct-Acting Antivirals. Patients, particularly those at risk of Hepatocellular Carcinoma (HCC), praise his proactive surveillance protocols. His early detection of liver tumours has allowed many to undergo curative treatments, providing hope where they previously feared a terminal diagnosis.

• Patient-Centred Care
  Dr. Jothimani believes in a holistic approach to liver health, particularly for transplant patients. He emphasises thorough counselling for patients and families, ensuring they understand the complexities of liver disease. His practice is built on the foundation of evidence-based medicine, honed during his extensive training in the UK.
• Technology & Innovation
  Dr. Jothimani utilises cutting-edge diagnostic tools such as Fibroscan for non-invasive fibrosis assessment and high-definition endoscopy for precise interventions. He is at the forefront of integrating new antiviral therapies and immunosuppressive protocols to improve transplant longevity and patient quality of life.

Treatment costs for liver procedures vary significantly based on the patient's condition, the type of donor (living vs deceased), and comorbidities. Below is an estimated cost structure.

Note: These are estimated costs. For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.

Language Support
The Cancer Rounds team facilitates communication for international patients, offering interpretation services to ensure clear understanding between the patient and Dr. Jothimani.

Visa & Travel Assistance
Cancer Rounds assists patients with Medical Visa invitations, travel logistics, airport transfers, and finding suitable accommodation near Dr. Rela Institute.

Pre-treatment Virtual Consultations
Patients can avail of video consultations to discuss their medical reports and treatment options with Dr. Jothimani before travelling to India, coordinated via Cancer Rounds.